Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

Managing chronic inflammation in the aging diabetic patient with CKD by diet or sevelamer carbonate: a modern paradigm shift.

The journals of gerontology. Series A, Biological sciences and medical sciences·2012

The value of failure: the discovery of TNF and its natural inhibitor erythropoietin.

Journal of internal medicine·2010

Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response.

Journal of internal medicine·2008

Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise.

Kidney international·2006

Differential expression of receptors for advanced glycation end-products in peritoneal mesothelial cells exposed to glucose degradation products.

Clinical and experimental immunology·2004

Erythropoietin: a candidate compound for neuroprotection in schizophrenia.

Molecular psychiatry·2003

Tarlatamab-Durvalumab Maintenance for Extensive-Stage Small-Cell Lung Cancer.

The New England journal of medicine·2026

Sacituzumab Tirumotecan plus Pembrolizumab in PD-L1-Negative Advanced NSCLC.

The New England journal of medicine·2026

Visualizing Cell Type-Specific Glycan Profiles in Tissue Sections With Glycan Painting.

Bio-protocol·2026

Genomic profiling of estrogen-related receptor identifies adult adipocyte-specific targets in Drosophila.

G3 (Bethesda, Md.)·2026

Sphingolipid Dysregulation in Type 2 Diabetes and Its Microvascular Complications.

International journal of molecular sciences·2026

β-cell adaptation to increased insulin demand is a swift and dynamic process orchestrated by unfolded protein response.

Cell communication and signaling : CCS·2026

Dual purine starvation triggers an Iml1-Whi2-dependent autophagy pathway for survival in yeast.

Autophagy·2026

Ubiquitylation of unbranched glycogen and glycogenin-1 in branching enzyme-deficient cells.

Biochemical and biophysical research communications·2026

Related Experiment Videos

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

Related Concept Videos

Managing chronic inflammation in the aging diabetic patient with CKD by diet or sevelamer carbonate: a modern paradigm shift.

The value of failure: the discovery of TNF and its natural inhibitor erythropoietin.

Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response.

Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise.

Differential expression of receptors for advanced glycation end-products in peritoneal mesothelial cells exposed to glucose degradation products.

Erythropoietin: a candidate compound for neuroprotection in schizophrenia.

Tarlatamab-Durvalumab Maintenance for Extensive-Stage Small-Cell Lung Cancer.

Sacituzumab Tirumotecan plus Pembrolizumab in PD-L1-Negative Advanced NSCLC.

Visualizing Cell Type-Specific Glycan Profiles in Tissue Sections With Glycan Painting.

Genomic profiling of estrogen-related receptor identifies adult adipocyte-specific targets in Drosophila.

Sphingolipid Dysregulation in Type 2 Diabetes and Its Microvascular Complications.

β-cell adaptation to increased insulin demand is a swift and dynamic process orchestrated by unfolded protein response.

Dual purine starvation triggers an Iml1-Whi2-dependent autophagy pathway for survival in yeast.

Ubiquitylation of unbranched glycogen and glycogenin-1 in branching enzyme-deficient cells.

Related Experiment Videos

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

Related Concept Videos

Related Articles